4-(4-Ethylpiperazin-1-ly)aniline - Names and Identifiers
4-(4-Ethylpiperazin-1-ly)aniline - Physico-chemical Properties
Molecular Formula | C12H19N3
|
Molar Mass | 205.3 |
Density | 1.065±0.06 g/cm3(Predicted) |
Melting Point | 76-78°C |
Boling Point | 364.4±37.0 °C(Predicted) |
Flash Point | 171.6°C |
Vapor Presure | 1.69E-05mmHg at 25°C |
pKa | 8.05±0.10(Predicted) |
Storage Condition | 2-8°C(protect from light) |
Refractive Index | 1.574 |
4-(4-Ethylpiperazin-1-ly)aniline - Risk and Safety
Hazard Symbols | Xi - Irritant
|
UN IDs | 3259 |
Hazard Class | IRRITANT |
Packing Group | Ⅲ |
4-(4-Ethylpiperazin-1-ly)aniline - Introduction
4-(4-Ethylpiperazin-1-yl) aniline, also known as DBU-PHARMA, is an organic compound. The following is a description of its nature, use, formulation and safety information:
Nature:
-Appearance: White crystalline solid
-Molecular formula: C15H23N3
-Molecular weight: 245.37g/mol
-Melting point: 118-122 degrees Celsius
-Solubility: Soluble in many polar organic solvents, such as ethanol and ether
Use:
- 4-(4-ethylpiperazin-1-yl) aniline is an important organic synthesis intermediate, widely used in pharmaceutical and pesticide industries.
-In the synthesis process, it is often used as a base catalyst and a transition metal complexing reagent.
-It has a significant effect on the activation and catalytic reactions of some organic compounds.
Method:
- 4-(4-ethylpiperazin-1-yl) aniline can be prepared by a synthetic route that includes the synthesis of ethylpiperazine and subsequent substitution reactions.
Safety Information:
- 4-(4-ethylpiperazin-1-yl) aniline is generally stable and relatively safe under general use conditions.
-However, because it is still an organic compound, proper laboratory handling and storage are required.
-Observe safe handling procedures when handling the compound, and pay attention to protective measures, such as wearing protective glasses and gloves.
-Detailed safety data and operating instructions should refer to the relevant safety data sheet of the compound.
Last Update:2024-04-10 22:29:15